Quest Diagnostics Inc (NYSE:DGX)
| 135.71 Delayed Data As of Nov 28 |  -0.01 / -0.01%Today’s Change | 119.59 Today|||52-Week Range 158.34 | -13.25% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 753.0M | 696.0M | 824.0M | 788.0M | |
| Depreciation | 304.0M | 249.0M | 270.0M | 309.0M | ||
| Total Other Cash Flow | 16.0M | 253.0M | 388.0M | 79.0M | ||
| Funds From Operations | 1.2B | 1.2B | 1.5B | 1.2B | ||
| Funds From/For Other Operating Expenses | 375.0M | 166.0M | 316.0M | 49.0M | ||
| Net Cash Flow - Operating Activities | 810.0M | 1.1B | 1.2B | 1.2B | ||
| Investing | Increase In Investments | -33.0M | 0.00 | 0.00 | 0.00 | |
| Capital Expenditures | -263.0M | -293.0M | -252.0M | -383.0M | ||
| Fixed Asset Disposal | 63.0M | 270.0M | 30.0M | 18.0M | ||
| Net Assets From Acquisitions | -67.0M | -139.0M | -581.0M | -421.0M | ||
| Other Investing - Sources | 1.0M | 10.0M | 2.0M | 1.0M | ||
| Net Cash Flow Investing | -299.0M | -152.0M | -801.0M | -785.0M | ||
| Financing | Short Term Borrowings | -- | -- | 0.00 | 0.00 | -- |
| Long Term Borrowings | 2.5B | 1.9B | 205.0M | 2.1B | ||
| Long Term Debt Reduction | -2.5B | -1.7B | -182.0M | -2.0B | ||
| Net Proceeds Stock Sale | 60.0M | 73.0M | 130.0M | 99.0M | ||
| Common Preferred Redeemed | -224.0M | -590.0M | -465.0M | -322.0M | ||
| Common Dividends | -212.0M | -223.0M | -247.0M | -266.0M | ||
| Cash Dividends Paid - Total | -212.0M | -223.0M | -247.0M | -266.0M | ||
| Other Sources - Financing | 5.0M | -- | 40.0M | 23.0M | ||
| Other Uses - Financing | 115.0M | 96.0M | 77.0M | 75.0M | ||
| Net Cash Flow - Financing | -570.0M | -691.0M | -596.0M | -417.0M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -59.0M | 226.0M | -222.0M | -2.0M | ||
